<--- Back to Details
First PageDocument Content
Pharmacology / Synthetic cannabis / National Institute on Drug Abuse / Methylenedioxypyrovalerone / Designer drug / Effects of cannabis / JWH-018 / Substance dependence / Cannabinoid / Euphoriants / Medicine / Chemistry
Date: 2014-11-13 15:03:35
Pharmacology
Synthetic cannabis
National Institute on Drug Abuse
Methylenedioxypyrovalerone
Designer drug
Effects of cannabis
JWH-018
Substance dependence
Cannabinoid
Euphoriants
Medicine
Chemistry

Spice, Bath Salts, and Behavior Health

Add to Reading List

Source URL: www.actmissouri.org

Download Document from Source Website

File Size: 271,85 KB

Share Document on Facebook

Similar Documents

FLUBROMAZEPAM Stephanie Hopkins, California Department of Justice, 4949 Broadway, Room F-249, Sacramento CA, Manufacturer: A “designer” drug. First described in 1962 by Sternbach (

DocID: 1u7eJ - View Document

FLUBROMAZEPAM Stephanie Hopkins, California Department of Justice, 4949 Broadway, Room F-249, Sacramento CA, Manufacturer: A “designer” drug. First described in 1962 by Sternbach (

DocID: 1u2MR - View Document

Ekctmchimica Acta,Vol.39.No. 4.ppCopyri&tt Q 1994 Elsevier Scicna Ltd. Printed inGreatBritainAU rights mewed

DocID: 1sNHy - View Document

LETTER 555 A Simple Protocol for Direct Reductive Amination of Aldehydes and Ketones Using Potassium Formate and Catalytic Palladium Acetate

DocID: 1stBf - View Document

TETRAHEDRON Pergamon Tetrahedron±5674 A modi®ed palladium catalysed reductive amination procedure

DocID: 1rDwT - View Document